ConductScience.org, home

Trial · NCT04750278

Registered outcomes21

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe Percentage of Patients Alive and Not Requiring Non-invasive or Invasive VentilationDay 28Percentage of patients alive and not requiring non-invasive or invasive ventilation at Day 28
SecondaryPercentage of Patients on Invasive Mechanical VentilationDay 28Percentage of patients on invasive mechanical ventilation at Day 28
SecondaryPercentage of Patients AliveDay 28Percentage of patients who are alive at the time of the assessment, day 28.
SecondaryPercentage of Patients Alive and Not Requiring Non-invasive or Invasive VentilationDay 60(ie, not receiving high flow nasal cannula, non-invasive positive pressure ventilation, invasive mechanical ventilation, or ECMO)
SecondaryPercentage of Patients on Invasive Mechanical VentilationDay 60Percentage of patients receiving high flow nasal cannula, non-invasive positive pressure ventilation, invasive mechanical ventilation, or ECMO at day 60
SecondaryPercentage of Patients AliveDay 60Percentage of patients who continue to be alive at day 60.
OtherQuantitative Assessment of Lung FibrosisDay 28 and Day 60Percentage of patients having lung fibrosis using high resolution, non-contrast CT scan, at days 28 and 60
OtherPercentage of Patients Who Were Randomized on Invasive Mechanical Ventilation Who Are Free of Invasive Mechanical VentilationDay 28 and at Day 60Percentage of patients at days 28 and 60 who improved to breathing on their own, after having been on mechanical ventilation at some point during their treatment.
OtherNumber of Ventilator Free Days (ie, Days Free of Invasive Mechanical Ventilation)Day 28 and Day 60Number of days (out of 28 and 60, respectively) that patient is off of mechanical ventilation.
OtherNumber of ICU Free DaysDay 28 and Day 60Number of days (out of 28 and 60, respectively) that the patient is not in the ICU
OtherNumber of Days in the HospitalDay 28 and Day 60Number of days (out of 28 and 60, respectively) that the patient is hospitalized.
OtherChange From Baseline in Peripheral Capillary Oxygen Saturation (SpO2)Day 28 and Day 60The number of percentage points the patient has changed in peripheral capillary oxygen saturation (SpO2) at days 28 and 60.
OtherChange From Baseline in Arterial Oxygen Partial Pressure (PaO2)/Fractional Inspired Oxygen (FiO2) RatioDay 28 and Day 60Change from baseline, at days 28 and 60, in arterial oxygen partial pressure .(PaO2)/fractional inspired oxygen (FiO2) ratio.
OtherPercentage of Patients Alive and Not HospitalizedDay 28 and Day 60Percentage of patients at day 28 and day 60 who are alive and not hospitalized.
OtherPercentage of Patients With Disease ProgressionDay 28 and Day 60(defined as a ≥ 2 point decrease in the NIAID 8 point ordinal scale score or death)
OtherPercentage of Patients Who Improve by ≥ 2 Points on the NIAID 8 Point Ordinal Scale ScoresDay 28 and Day 60Percentage of patients who improve by ≥ 2 points on the NIAID 8 point ordinal scale scores at Day 28 and Day 60
OtherPulmonary Function TestDay 28 and Day 60Measured by Forced Expiratory Volume in 1 second (FEV1) /Forced Vital Capacity (FVC) at Day 28 and Day 60
OtherChange From Baseline in eGFRDay 28 and Day 60Change from baseline in eGFR at day 28 and day 60.
OtherChange From Baseline in Blood Urea NitrogenDay 28 and Day 60Change .from baseline in blood urea nitrogen at day 28 and day 60
OtherChange From Baseline in Serum CreatinineDay 28 and Day 60Change from baseline in serum creatinine at day 28 and day 60.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04750278/registered